Table 3.
Eye | Preoperatively | 6 months after CXL | At diagnosis of progression | Sign of progression | One year after CXL redo | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
K1 | K2 | kmax | K′1 | K′2 | K′max | K′′1 | K′′2 | K′′max | K ∧1 | K ∧2 | K ∧3 | ||
Eye 1 | 40.6 | 50.2 | 53.9 | 41.2 | 45.5 | 50.7 | 42.1 | 46.2 | 51.3 |
#
k1: 0.9 D,
# K max 0.6 D ↓CDVA |
42.00 | 45.8 | 51.00 |
Eye 2 | 45.2 | 48.9 | 51.3 | 42.93 | 45.45 | ∗ | 43.15 | 46.67 | ∗ | # k2 1.22 D | 43.00 | 46.87 | ∗ |
Eye 3 | 53.53 | 60.25 | 67.5 | 40.84 | 41.16 | 45.22 | 40.5 | 43.38 | 49.97 |
#
k2: 1.84 D
# k max 4.75 D |
40.00 | 43.25 | 49.80 |
Eye 4 | 51.6 | 55.1 | 57.1 | 52.7 | 54.38 | ∗ | 53.2 | 55.06 | ∗ |
#
k1 0.5 D #
k
max 0.68 D
↓CDVA |
52.98 | 54.9 | ∗ |
Eye 5 | 54.5 | 56.8 | 63.2 | 48.3 | 51.4 | ∗ | 57.05 | 59.33 | ∗ |
#
k1 8.75 D
# k2 7.92 D |
56.8 | 59.2 | ∗ |
Eye 6 | ∗ | ∗ | ∗ | 44.07 | 47.45 | 59.4 | 44.49 | 47.5 | 62.11 | # k max 2.71 D | 44.3 | 46.9 | 61.89 |
Eye 7 | ∗ | ∗ | ∗ | 47.69 | 50.05 | 59.51 | 47.74 | 49.71 | 61.7 | # k max 2.19 D | 47.8 | 49.59 | 61.2 |